MDT

98.84

+0.35%↑

144.96

-0.77%↓

VEEV

219.1

+0.44%↑

HQY

86.84

+1.35%↑

NEOG

9.45

+0.43%↑

MDT

98.84

+0.35%↑

144.96

-0.77%↓

VEEV

219.1

+0.44%↑

HQY

86.84

+1.35%↑

NEOG

9.45

+0.43%↑

MDT

98.84

+0.35%↑

144.96

-0.77%↓

VEEV

219.1

+0.44%↑

HQY

86.84

+1.35%↑

NEOG

9.45

+0.43%↑

MDT

98.84

+0.35%↑

144.96

-0.77%↓

VEEV

219.1

+0.44%↑

HQY

86.84

+1.35%↑

NEOG

9.45

+0.43%↑

MDT

98.84

+0.35%↑

144.96

-0.77%↓

VEEV

219.1

+0.44%↑

HQY

86.84

+1.35%↑

NEOG

9.45

+0.43%↑

Kodu・Aktsiate loetelu・Vivani Medical

Vivani Medical

Suletud

1.25 -0.79

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

1.23

Max

1.28

Põhinäitajad
By Trading Economics
Töötajad	37

Soovitused
By TipRanks
Soovitused	Osta
12 kuu keskmine prognoos	+212.5% upside

Dividendid
By Dow Jones
Järgmine tulemuste avaldamine	30. märts 2026

Turustatistika
By TradingEconomics
Turukapital	-20M 85M
Eelmine avamishind	2.04
Eelmine sulgemishind	1.25

Vivani Medical Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

15. jaan 2026, 18:44 UTC

Suurimad hinnamuutused turgudel

Agenus Falls After $141 Million Zydus Deal Closes

15. jaan 2026, 17:51 UTC

Suurimad hinnamuutused turgudel

Galaxy Digital Climbs on Texas Data-Center Expansion Approval, Tokenized CLO Issuance

15. jaan 2026, 17:25 UTC

Suurimad hinnamuutused turgudel

ASML Exceeds $500 Billion in Market Value on TSMC's Blockbuster Spending Plans -- Update

15. jaan 2026, 23:48 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

15. jaan 2026, 23:48 UTC

Market Talk

Nikkei May Decline as Enthusiasm Over Election Eases -- Market Talk

15. jaan 2026, 23:40 UTC

Market Talk

Gold Edges Lower Amid Abating Geopolitical Risks -- Market Talk

15. jaan 2026, 23:11 UTC

Market Talk

Global Equities Roundup: Market Talk

15. jaan 2026, 23:11 UTC

Market Talk

Ryman Healthcare's Resales Remain Key Concern -- Market Talk

15. jaan 2026, 23:01 UTC

Market Talk

New Zealand's Economy Enters An Upswing -- Market Talk

15. jaan 2026, 22:56 UTC

Market Talk

Tulu

Catalyst Metals Delivers a Beat With Record Gold Output -- Market Talk

15. jaan 2026, 22:51 UTC

Market Talk

James Hardie's Plant Closures Could Boost Profit by 2%-3% -- Market Talk

15. jaan 2026, 22:19 UTC

Omandamised, ülevõtmised, äriostud

Verizon Gets Final California Approval to Secure $9.6 Billion Frontier Deal -- WSJ

15. jaan 2026, 21:50 UTC

Market Talk

Tulu

Financial Services Roundup: Market Talk

15. jaan 2026, 21:50 UTC

Market Talk

Omandamised, ülevõtmised, äriostud

Energy & Utilities Roundup: Market Talk

15. jaan 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

15. jaan 2026, 21:27 UTC

Tulu

BlackRock Caps 2025 With Record $14 Trillion in Assets -- 3rd Update

15. jaan 2026, 21:15 UTC

Market Talk

Omandamised, ülevõtmised, äriostud

Global Commodities Roundup: Market Talk

15. jaan 2026, 21:11 UTC

Market Talk

Omandamised, ülevõtmised, äriostud

Global Equities Roundup: Market Talk

15. jaan 2026, 21:11 UTC

Market Talk

Omandamised, ülevõtmised, äriostud

Canada Antitrust Watchdog Confirms Review of Canadian Energy Deal -- Market Talk

15. jaan 2026, 20:10 UTC

Market Talk

U.S. Natural Gas Futures Settle Mixed -- Market Talk

15. jaan 2026, 20:04 UTC

Tulu

These Stocks Are Today's Movers: TSMC, ASML, Goldman, Morgan Stanley, BlackRock, Coinbase, Sandisk, and More -- Barrons.com

15. jaan 2026, 20:03 UTC

Market Talk

Oil Futures Fall As Iran Risk Premium Fades -- Market Talk

15. jaan 2026, 19:26 UTC

Market Talk

Silver Closes at Fresh High -- Market Talk

15. jaan 2026, 18:29 UTC

Suurimad hinnamuutused turgudel

Agenus Falls After $141M Zydus Deal Closes

15. jaan 2026, 18:20 UTC

Tulu

Wall Street Powers Nation's Biggest Banks to Record Year -- WSJ

15. jaan 2026, 17:56 UTC

Market Talk

Tulu

U.S. Bank Results Look Encouraging for European Peers -- Market Talk

15. jaan 2026, 17:20 UTC

Market Talk

Omandamised, ülevõtmised, äriostud

Auto & Transport Roundup: Market Talk

15. jaan 2026, 17:20 UTC

Market Talk

Health Care Roundup: Market Talk

15. jaan 2026, 17:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

15. jaan 2026, 17:02 UTC

Omandamised, ülevõtmised, äriostud

KBC Group Completes Acquisition of 98.45% Stake in 365.bank From J&T Finance Group

Võrdlus sarnastega

Hinnamuutus

Vivani Medical Prognoos

Hinnasiht

By TipRanks

212.5% tõus

12 kuu keskmine prognoos

Keskmine 4 USD 212.5%

Kõrge 4 USD

Madal 4 USD

Põhineb 2 Wall Streeti analüütiku instrumendi Vivani Medical 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

2 ratings

Osta

Hoia

Müü

Põhineb 2 analüütiku instrumendi Vivani Medical aktsia reitingul - viimase 3 kuu andmed.

Finantsandmed

Ettevõttest Vivani Medical

Vivani Medical, Inc., a preclinical stage biopharmaceutical company, engages in the development of miniaturized and subdermal implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates in the treatment of chronic disease, medication non-adherence. Its pipeline includes NPM-115, a high-dose exenatide implant candidate is in preclinical stage development for the treatment of chronic weight management in patients with obesity or overweight; NPM-119, an exenatide implant candidate is in preclinical stage development for the treatment of patients with type 2 diabetes; NPM-139, a miniature, subdermal GLP-1 implant in development for chronic weight management; and OKV-119, an exenatide implant is under development for metabolic diseases in cats including for the treatment of obesity and diabetes. The company is headquartered in Alameda, California.